
Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Description
Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Collagens pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Collagens includes dressings that are typically made up of a combination of animal collagen and any other formulation (such as cellulose or alginates) for structural integrity, and sodium or calcium ions.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Collagens under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Collagens and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Collagens under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
97 Pages
- About GlobalData
- Collagens Overview
- Collagens - Pipeline Products by Stage of Development
- Collagens - Pipeline Products by Segment
- Collagens - Pipeline Products by Territory
- Collagens - Pipeline Products by Regulatory Path
- Collagens - Pipeline Products by Estimated Approval Date
- Collagens - Ongoing Clinical Trials
- Collagens Companies - Pipeline Products by Stage of Development
- Collagens - Companies Pipeline Products by Stage of Development
- Acro Biomedical Co Ltd Company Overview
- Advanced Biotech Products Pvt Ltd Company Overview
- Advanced Medical Solutions Group plc Company Overview
- AGAM Biological Products Company Overview
- Altach AG Company Overview
- Altrazeal Life Sciences Inc Company Overview
- Baxter International Inc Company Overview
- Biovotec AS Company Overview
- Collagen Solutions Ltd Company Overview
- Collplant Biotechnologies Ltd Company Overview
- Colzyx AB Company Overview
- Conversion Energy Enterprises Company Overview
- Covalon Technologies Ltd Company Overview
- Ension, Inc. Company Overview
- EternoGen Aesthetics LLC Company Overview
- Gene Biotherapeutics Inc Company Overview
- GeniPhys LLC Company Overview
- Giant Biogene Holding Co Ltd Company Overview
- Harbor MedTech Inc Company Overview
- Holista CollTech Ltd Company Overview
- Innocoll Technologies Ltd (Inactive) Company Overview
- Jellagen Ltd Company Overview
- Keranetics LLC Company Overview
- Lattice Biologics Ltd Company Overview
- Leader Biomedical Europe BV Company Overview
- Medtronic Plc Company Overview
- Michigan State University Company Overview
- MiMedx Group Inc Company Overview
- Nanotherapeutics Inc (Inactive) Company Overview
- Orbsen Therapeutics Ltd Company Overview
- PlasMedica Technologies Limited Company Overview
- Purdue University Company Overview
- Qinghai Chuangming Medical Equipment Co Ltd Company Overview
- Shire Pharmaceuticals International UC Company Overview
- Tel Aviv University Company Overview
- VA Palo Alto Health Care System Company Overview
- Wound Care Innovations LLC Company Overview
- Dec 08, 2023: OCM Wound Platform Demonstrates Antibacterial Activity in Porcine Wound Model, Significantly Reducing Methicillin-Resistant Staphylococcus Aureus (MRSA) and Pseudomonas Aeruginosa (PA) Compared to Comparator and Control Groups
- Dec 06, 2023: Maxigen Biotech Receives 510(K) Clearance For HealiAid Dental Collagen Wound Dressing
- Dec 06, 2023: New Clinical Data Demonstrate 90 Percent Area Reduction in Diabetic Foot Ulcers within 12 Weeks or less Using Novel Omeza Platform plus Offloading
- Nov 30, 2023: Sanara MedTech Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX Surgical Powder) Was Used to Promote Wound Healing
- Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
- Oct 03, 2023: Baxter Appoints Joel Grade Chief Financial Officer
- Oct 02, 2023: Advanced Medical Solutions Group Announces Appointment of New Chair
- Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
- Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
- Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
- Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary
- Aug 10, 2023: Advanced Medical Solutions Group Notice of Interim Results
- Aug 09, 2023: Collplant Biotechnologies Announces Date for 2023 Second Quarter Financial Results and Conference Call Information
- Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
- Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023
- Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO
- Jun 26, 2023: Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 - 28, 2023 in Orlando, Florida
- Jun 13, 2023: Breakthrough Solution for Fragile Skin: Covalon's IV Clear Dressing Recommended by Physicians at a Top 10 U.S. Children's Hospital and Epidermolysis Bullosa Center of Excellence
- May 24, 2023: CollPlant Biotechnologies announces first quarter financial results for 2023 and provides corporate update
- May 16, 2023: Covalon, leader in compassionate pediatric infection prevention solutions, to participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023
- May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
- Apr 28, 2023: Kerecis launches new MariGen Shield to treat wounds
- Apr 12, 2023: Medtronic has a layoff in California
- Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director
- Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format
- Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting
- Mar 20, 2023: Leader in compassionate care infection prevention solutions, Covalon, to participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023
- Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
- Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022
- Mar 09, 2023: Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders
- Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.